Global Loxoprofen API (Sodium Salt) Market Analysis and Forecast 2025-2031

Summary

According to APO Research, The global Loxoprofen API (Sodium Salt) market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Loxoprofen API (Sodium Salt) is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Loxoprofen API (Sodium Salt) is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Loxoprofen API (Sodium Salt) is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Loxoprofen API (Sodium Salt) is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Loxoprofen API (Sodium Salt) include Anlon Healthcare, Daiichi Sankyo, Metrochem, Shinpoong Pharm, Dongyue Pharma, Hunan Jiudian Hongyang, Luoxin Pharmaceutical, Apeloa Pharmaceutical and Zhejiang Starry Pharmaceutical, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Loxoprofen API (Sodium Salt), sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Loxoprofen API (Sodium Salt), also provides the sales of main regions and countries. Of the upcoming market potential for Loxoprofen API (Sodium Salt), and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Loxoprofen API (Sodium Salt) sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Loxoprofen API (Sodium Salt) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Loxoprofen API (Sodium Salt) sales, projected growth trends, production technology, application and end-user industry.

Loxoprofen API (Sodium Salt) Segment by Company

Anlon Healthcare
Daiichi Sankyo
Metrochem
Shinpoong Pharm
Dongyue Pharma
Hunan Jiudian Hongyang
Luoxin Pharmaceutical
Apeloa Pharmaceutical
Zhejiang Starry Pharmaceutical

Loxoprofen API (Sodium Salt) Segment by Type

Purity ≥99%
Purity<99%

Loxoprofen API (Sodium Salt) Segment by Application

Oral Dosage
External Preparation

Loxoprofen API (Sodium Salt) Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Loxoprofen API (Sodium Salt) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Loxoprofen API (Sodium Salt) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Loxoprofen API (Sodium Salt).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Loxoprofen API (Sodium Salt) in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Loxoprofen API (Sodium Salt) manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Loxoprofen API (Sodium Salt) sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.


1 Market Overview
1.1 Product Definition
1.2 Loxoprofen API (Sodium Salt) Market by Type
1.2.1 Global Loxoprofen API (Sodium Salt) Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Purity ≥99%
1.2.3 Purity<99%
1.3 Loxoprofen API (Sodium Salt) Market by Application
1.3.1 Global Loxoprofen API (Sodium Salt) Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Oral Dosage
1.3.3 External Preparation
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Loxoprofen API (Sodium Salt) Market Dynamics
2.1 Loxoprofen API (Sodium Salt) Industry Trends
2.2 Loxoprofen API (Sodium Salt) Industry Drivers
2.3 Loxoprofen API (Sodium Salt) Industry Opportunities and Challenges
2.4 Loxoprofen API (Sodium Salt) Industry Restraints
3 Global Market Growth Prospects
3.1 Global Loxoprofen API (Sodium Salt) Revenue Estimates and Forecasts (2020-2031)
3.2 Global Loxoprofen API (Sodium Salt) Revenue by Region
3.2.1 Global Loxoprofen API (Sodium Salt) Revenue by Region: 2020 VS 2024 VS 2031
3.2.2 Global Loxoprofen API (Sodium Salt) Revenue by Region (2020-2025)
3.2.3 Global Loxoprofen API (Sodium Salt) Revenue by Region (2026-2031)
3.2.4 Global Loxoprofen API (Sodium Salt) Revenue Market Share by Region (2020-2031)
3.3 Global Loxoprofen API (Sodium Salt) Sales Estimates and Forecasts 2020-2031
3.4 Global Loxoprofen API (Sodium Salt) Sales by Region
3.4.1 Global Loxoprofen API (Sodium Salt) Sales by Region: 2020 VS 2024 VS 2031
3.4.2 Global Loxoprofen API (Sodium Salt) Sales by Region (2020-2025)
3.4.3 Global Loxoprofen API (Sodium Salt) Sales by Region (2026-2031)
3.4.4 Global Loxoprofen API (Sodium Salt) Sales Market Share by Region (2020-2031)
3.5 US & Canada & Mexico
3.6 Europe
3.7 China
3.8 Asia (Excluding China)
3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
4.1 Global Loxoprofen API (Sodium Salt) Revenue by Manufacturers
4.1.1 Global Loxoprofen API (Sodium Salt) Revenue by Manufacturers (2020-2025)
4.1.2 Global Loxoprofen API (Sodium Salt) Revenue Market Share by Manufacturers (2020-2025)
4.1.3 Global Loxoprofen API (Sodium Salt) Manufacturers Revenue Share Top 10 and Top 5 in 2024
4.2 Global Loxoprofen API (Sodium Salt) Sales by Manufacturers
4.2.1 Global Loxoprofen API (Sodium Salt) Sales by Manufacturers (2020-2025)
4.2.2 Global Loxoprofen API (Sodium Salt) Sales Market Share by Manufacturers (2020-2025)
4.2.3 Global Loxoprofen API (Sodium Salt) Manufacturers Sales Share Top 10 and Top 5 in 2024
4.3 Global Loxoprofen API (Sodium Salt) Sales Price by Manufacturers (2020-2025)
4.4 Global Loxoprofen API (Sodium Salt) Key Manufacturers Ranking, 2023 VS 2024 VS 2025
4.5 Global Loxoprofen API (Sodium Salt) Key Manufacturers Manufacturing Sites & Headquarters
4.6 Global Loxoprofen API (Sodium Salt) Manufacturers, Product Type & Application
4.7 Global Loxoprofen API (Sodium Salt) Manufacturers' Establishment Date
4.8 Market Competitive Analysis
4.8.1 Global Loxoprofen API (Sodium Salt) Market CR5 and HHI
4.8.2 2024 Loxoprofen API (Sodium Salt) Tier 1, Tier 2, and Tier 3
5 Loxoprofen API (Sodium Salt) Market by Type
5.1 Global Loxoprofen API (Sodium Salt) Revenue by Type
5.1.1 Global Loxoprofen API (Sodium Salt) Revenue by Type (2020 VS 2024 VS 2031)
5.1.2 Global Loxoprofen API (Sodium Salt) Revenue by Type (2020-2031) & (US$ Million)
5.1.3 Global Loxoprofen API (Sodium Salt) Revenue Market Share by Type (2020-2031)
5.2 Global Loxoprofen API (Sodium Salt) Sales by Type
5.2.1 Global Loxoprofen API (Sodium Salt) Sales by Type (2020 VS 2024 VS 2031)
5.2.2 Global Loxoprofen API (Sodium Salt) Sales by Type (2020-2031) & (Tons)
5.2.3 Global Loxoprofen API (Sodium Salt) Sales Market Share by Type (2020-2031)
5.3 Global Loxoprofen API (Sodium Salt) Price by Type
6 Loxoprofen API (Sodium Salt) Market by Application
6.1 Global Loxoprofen API (Sodium Salt) Revenue by Application
6.1.1 Global Loxoprofen API (Sodium Salt) Revenue by Application (2020 VS 2024 VS 2031)
6.1.2 Global Loxoprofen API (Sodium Salt) Revenue by Application (2020-2031) & (US$ Million)
6.1.3 Global Loxoprofen API (Sodium Salt) Revenue Market Share by Application (2020-2031)
6.2 Global Loxoprofen API (Sodium Salt) Sales by Application
6.2.1 Global Loxoprofen API (Sodium Salt) Sales by Application (2020 VS 2024 VS 2031)
6.2.2 Global Loxoprofen API (Sodium Salt) Sales by Application (2020-2031) & (Tons)
6.2.3 Global Loxoprofen API (Sodium Salt) Sales Market Share by Application (2020-2031)
6.3 Global Loxoprofen API (Sodium Salt) Price by Application
7 Company Profiles
7.1 Anlon Healthcare
7.1.1 Anlon Healthcare Comapny Information
7.1.2 Anlon Healthcare Business Overview
7.1.3 Anlon Healthcare Loxoprofen API (Sodium Salt) Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 Anlon Healthcare Loxoprofen API (Sodium Salt) Product Portfolio
7.1.5 Anlon Healthcare Recent Developments
7.2 Daiichi Sankyo
7.2.1 Daiichi Sankyo Comapny Information
7.2.2 Daiichi Sankyo Business Overview
7.2.3 Daiichi Sankyo Loxoprofen API (Sodium Salt) Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 Daiichi Sankyo Loxoprofen API (Sodium Salt) Product Portfolio
7.2.5 Daiichi Sankyo Recent Developments
7.3 Metrochem
7.3.1 Metrochem Comapny Information
7.3.2 Metrochem Business Overview
7.3.3 Metrochem Loxoprofen API (Sodium Salt) Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 Metrochem Loxoprofen API (Sodium Salt) Product Portfolio
7.3.5 Metrochem Recent Developments
7.4 Shinpoong Pharm
7.4.1 Shinpoong Pharm Comapny Information
7.4.2 Shinpoong Pharm Business Overview
7.4.3 Shinpoong Pharm Loxoprofen API (Sodium Salt) Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 Shinpoong Pharm Loxoprofen API (Sodium Salt) Product Portfolio
7.4.5 Shinpoong Pharm Recent Developments
7.5 Dongyue Pharma
7.5.1 Dongyue Pharma Comapny Information
7.5.2 Dongyue Pharma Business Overview
7.5.3 Dongyue Pharma Loxoprofen API (Sodium Salt) Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 Dongyue Pharma Loxoprofen API (Sodium Salt) Product Portfolio
7.5.5 Dongyue Pharma Recent Developments
7.6 Hunan Jiudian Hongyang
7.6.1 Hunan Jiudian Hongyang Comapny Information
7.6.2 Hunan Jiudian Hongyang Business Overview
7.6.3 Hunan Jiudian Hongyang Loxoprofen API (Sodium Salt) Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Hunan Jiudian Hongyang Loxoprofen API (Sodium Salt) Product Portfolio
7.6.5 Hunan Jiudian Hongyang Recent Developments
7.7 Luoxin Pharmaceutical
7.7.1 Luoxin Pharmaceutical Comapny Information
7.7.2 Luoxin Pharmaceutical Business Overview
7.7.3 Luoxin Pharmaceutical Loxoprofen API (Sodium Salt) Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 Luoxin Pharmaceutical Loxoprofen API (Sodium Salt) Product Portfolio
7.7.5 Luoxin Pharmaceutical Recent Developments
7.8 Apeloa Pharmaceutical
7.8.1 Apeloa Pharmaceutical Comapny Information
7.8.2 Apeloa Pharmaceutical Business Overview
7.8.3 Apeloa Pharmaceutical Loxoprofen API (Sodium Salt) Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 Apeloa Pharmaceutical Loxoprofen API (Sodium Salt) Product Portfolio
7.8.5 Apeloa Pharmaceutical Recent Developments
7.9 Zhejiang Starry Pharmaceutical
7.9.1 Zhejiang Starry Pharmaceutical Comapny Information
7.9.2 Zhejiang Starry Pharmaceutical Business Overview
7.9.3 Zhejiang Starry Pharmaceutical Loxoprofen API (Sodium Salt) Sales, Revenue, Price and Gross Margin (2020-2025)
7.9.4 Zhejiang Starry Pharmaceutical Loxoprofen API (Sodium Salt) Product Portfolio
7.9.5 Zhejiang Starry Pharmaceutical Recent Developments
8 North America
8.1 North America Loxoprofen API (Sodium Salt) Market Size by Type
8.1.1 North America Loxoprofen API (Sodium Salt) Revenue by Type (2020-2031)
8.1.2 North America Loxoprofen API (Sodium Salt) Sales by Type (2020-2031)
8.1.3 North America Loxoprofen API (Sodium Salt) Price by Type (2020-2031)
8.2 North America Loxoprofen API (Sodium Salt) Market Size by Application
8.2.1 North America Loxoprofen API (Sodium Salt) Revenue by Application (2020-2031)
8.2.2 North America Loxoprofen API (Sodium Salt) Sales by Application (2020-2031)
8.2.3 North America Loxoprofen API (Sodium Salt) Price by Application (2020-2031)
8.3 North America Loxoprofen API (Sodium Salt) Market Size by Country
8.3.1 North America Loxoprofen API (Sodium Salt) Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
8.3.2 North America Loxoprofen API (Sodium Salt) Sales by Country (2020 VS 2024 VS 2031)
8.3.3 North America Loxoprofen API (Sodium Salt) Price by Country (2020-2031)
8.3.4 United States
8.3.5 Canada
8.3.6 Mexico
9 Europe
9.1 Europe Loxoprofen API (Sodium Salt) Market Size by Type
9.1.1 Europe Loxoprofen API (Sodium Salt) Revenue by Type (2020-2031)
9.1.2 Europe Loxoprofen API (Sodium Salt) Sales by Type (2020-2031)
9.1.3 Europe Loxoprofen API (Sodium Salt) Price by Type (2020-2031)
9.2 Europe Loxoprofen API (Sodium Salt) Market Size by Application
9.2.1 Europe Loxoprofen API (Sodium Salt) Revenue by Application (2020-2031)
9.2.2 Europe Loxoprofen API (Sodium Salt) Sales by Application (2020-2031)
9.2.3 Europe Loxoprofen API (Sodium Salt) Price by Application (2020-2031)
9.3 Europe Loxoprofen API (Sodium Salt) Market Size by Country
9.3.1 Europe Loxoprofen API (Sodium Salt) Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
9.3.2 Europe Loxoprofen API (Sodium Salt) Sales by Country (2020 VS 2024 VS 2031)
9.3.3 Europe Loxoprofen API (Sodium Salt) Price by Country (2020-2031)
9.3.4 Germany
9.3.5 France
9.3.6 U.K.
9.3.7 Italy
9.3.8 Russia
9.3.9 Spain
9.3.10 Netherlands
10 China
10.1 China Loxoprofen API (Sodium Salt) Market Size by Type
10.1.1 China Loxoprofen API (Sodium Salt) Revenue by Type (2020-2031)
10.1.2 China Loxoprofen API (Sodium Salt) Sales by Type (2020-2031)
10.1.3 China Loxoprofen API (Sodium Salt) Price by Type (2020-2031)
10.2 China Loxoprofen API (Sodium Salt) Market Size by Application
10.2.1 China Loxoprofen API (Sodium Salt) Revenue by Application (2020-2031)
10.2.2 China Loxoprofen API (Sodium Salt) Sales by Application (2020-2031)
10.2.3 China Loxoprofen API (Sodium Salt) Price by Application (2020-2031)
11 Asia (Excluding China)
11.1 Asia Loxoprofen API (Sodium Salt) Market Size by Type
11.1.1 Asia Loxoprofen API (Sodium Salt) Revenue by Type (2020-2031)
11.1.2 Asia Loxoprofen API (Sodium Salt) Sales by Type (2020-2031)
11.1.3 Asia Loxoprofen API (Sodium Salt) Price by Type (2020-2031)
11.2 Asia Loxoprofen API (Sodium Salt) Market Size by Application
11.2.1 Asia Loxoprofen API (Sodium Salt) Revenue by Application (2020-2031)
11.2.2 Asia Loxoprofen API (Sodium Salt) Sales by Application (2020-2031)
11.2.3 Asia Loxoprofen API (Sodium Salt) Price by Application (2020-2031)
11.3 Asia Loxoprofen API (Sodium Salt) Market Size by Country
11.3.1 Asia Loxoprofen API (Sodium Salt) Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
11.3.2 Asia Loxoprofen API (Sodium Salt) Sales by Country (2020 VS 2024 VS 2031)
11.3.3 Asia Loxoprofen API (Sodium Salt) Price by Country (2020-2031)
11.3.4 Japan
11.3.5 South Korea
11.3.6 India
11.3.7 Australia
11.3.8 Taiwan
11.3.9 Southeast Asia
12 South America, Middle East and Africa
12.1 SAMEA Loxoprofen API (Sodium Salt) Market Size by Type
12.1.1 SAMEA Loxoprofen API (Sodium Salt) Revenue by Type (2020-2031)
12.1.2 SAMEA Loxoprofen API (Sodium Salt) Sales by Type (2020-2031)
12.1.3 SAMEA Loxoprofen API (Sodium Salt) Price by Type (2020-2031)
12.2 SAMEA Loxoprofen API (Sodium Salt) Market Size by Application
12.2.1 SAMEA Loxoprofen API (Sodium Salt) Revenue by Application (2020-2031)
12.2.2 SAMEA Loxoprofen API (Sodium Salt) Sales by Application (2020-2031)
12.2.3 SAMEA Loxoprofen API (Sodium Salt) Price by Application (2020-2031)
12.3 SAMEA Loxoprofen API (Sodium Salt) Market Size by Country
12.3.1 SAMEA Loxoprofen API (Sodium Salt) Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
12.3.2 SAMEA Loxoprofen API (Sodium Salt) Sales by Country (2020 VS 2024 VS 2031)
12.3.3 SAMEA Loxoprofen API (Sodium Salt) Price by Country (2020-2031)
12.3.4 Brazil
12.3.5 Argentina
12.3.6 Chile
12.3.7 Colombia
12.3.8 Peru
12.3.9 Saudi Arabia
12.3.10 Israel
12.3.11 UAE
12.3.12 Turkey
12.3.13 Iran
12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
13.1 Loxoprofen API (Sodium Salt) Value Chain Analysis
13.1.1 Loxoprofen API (Sodium Salt) Key Raw Materials
13.1.2 Raw Materials Key Suppliers
13.1.3 Manufacturing Cost Structure
13.1.4 Loxoprofen API (Sodium Salt) Production Mode & Process
13.2 Loxoprofen API (Sodium Salt) Sales Channels Analysis
13.2.1 Direct Comparison with Distribution Share
13.2.2 Loxoprofen API (Sodium Salt) Distributors
13.2.3 Loxoprofen API (Sodium Salt) Customers
14 Concluding Insights
15 Appendix
15.1 Reasons for Doing This Study
15.2 Research Methodology
15.3 Research Process
15.4 Authors List of This Report
15.5 Data Source
15.5.1 Secondary Sources
15.5.2 Primary Sources
15.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings